Evidence map›Paper›PMID 30915356›Full record

ArticleBioMed research international2019

C

Xiu-Ying He, Liu-Lin Xiong, Qing-Jie Xia, Yang-Yang Wang, Xiao-Ming Zhao, Ruo-Lan Du, Jin Huang, Xiao-Qiong He, Jia-Liu, Ting-Hua Wang

Erratum issuedOpen access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Correction to "CBioMed research international · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Combined Scutellarin and CFrontiers in oncology · 2021
    Article
  9. Article
  10. C₁₈H₁₇NO₆ Inhibits Invasion and Migration of Human MNNG Osteosarcoma Cells via the PI3K/AKT Signaling Pathway.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Xiu-Ying He *Institute of Neurological Disease, Department of Anesthesiology, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0001-6320-9766
Liu-Lin Xiong *Department of Anesthesiology, Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China.ORCID 0000-0002-8359-7417
Qing-Jie XiaInstitute of Neurological Disease, Department of Anesthesiology, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu, China.
Yang-Yang WangInstitute of Neurological Disease, Department of Anesthesiology, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu, China.
Xiao-Ming ZhaoDepartment of Histology, Embryology and Neurobiology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, China.
Ruo-Lan DuInstitute of Neurological Disease, Department of Anesthesiology, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu, China.
Jin HuangInstitute of Neuroscience, Laboratory Zoology Department, Kunming Medical University, Kunming, China.
Xiao-Qiong He *School of Public Health, Kunming Medical University, Kunming, China.ORCID 0000-0003-4357-2482
Jia-Liu *Institute of Neuroscience, Laboratory Zoology Department, Kunming Medical University, Kunming, China.ORCID 0000-0001-5678-7437
Ting-Hua Wang *Institute of Neurological Disease, Department of Anesthesiology, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0002-5353-4810
Sichuan University · CNKunming Medical University · CNSouthwest Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlioma is the most common malignant brain tumor and the patients are prone to poor prognosis. Due to limited treatments, new drug exploration has become a general trend. Therefore, the objective of this study is to investigate the effect of the new drugs C

methodU251 and LN229 cells were administrated with C

resultThe results showed that, with the increasing dose of C

conclusionC

Indexed as

Brain NeoplasmsGliomaAdaptor Proteins, Signal TransducingApigeninApoptosisApoptosis Regulatory ProteinsCell Line, TumorCell ProliferationDose-Response Relationship, DrugGene Expression Regulation, NeoplasticGlucuronatesHumansNeoplasm ProteinsAdaptor Proteins, Signal TransducingApigeninApoptosis Regulatory ProteinsFAF1 protein, humanGlucuronatesNeoplasm Proteinsscutellarin

Identifiers

PMID30915356
PMCPMC6402243
OpenAlexW2915351480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.